UG Healthcare returns to profit in FY26 with S$2.1 million net profit; revenue rises 4.7% to S$150.82 million
Reuters2026/08/26 14:08- UG Healthcare returned to profit in FY26, posting net profit of S$2.1 million versus a net loss of S$4.1 million.
- Revenue rose 4.7% to S$150.82 million, due to higher sales volume and improved average selling prices for disposable examination gloves.
- Gross margin widened 4.3 percentage points to 28.4%, as the group cited better operational efficiency and prudent resource management.
- EBITDA more than doubled to S$12.4 million, supported by process efficiency initiatives across upstream and downstream operations.
- Management expects to progressively commercialize its third manufacturing facility in Q1 calendar 2027 following trial production.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Electra Therapeutics (ETRA.US) submits US IPO application, leveraging the biotech IPO boom to advance new drug development for immune diseases and cancer.
Electra Therapeutics Inc. has officially filed for an initial public offering (IPO), aiming to leverage the strong IPO performance of the biotechnology sector this year to raise funds for its clinical-stage pipeline of drugs targeting immune-mediated diseases and cancer.
Fogo Foundation Attacked, Approximately 400 Million FOGO Tokens Transferred
Blue Owl (OWL.US) teams up with PIMCO to tailor a $2.4 billion GPU financing for IREN (IREN.US)
A $2.4 billions debt financing round, led by funds under Blue Owl Capital Inc., has been finalized. The funds will be allocated to cloud service provider IREN Ltd. to purchase NVIDIA's Blackwell Ultra GPUs, supporting the development of its data center campus in Canada.
Crypto prices
More
